Celera: Providing Actionable Diagnostic & Genomic Solutions
About UsProduct PipelineResearch & DevelopmentInvestors & MediaCareers

Advanced technologies. Advanced therapies.

Leadership in Targeted Medicine

Celera is a diagnostics business delivering personalized disease management solutions through a combination of tests and services based on proprietary genetics discovery platforms. [ Read more ]
Targeted Medicine
Berkeley HeartLab
Read About Celera's Strategic Alliances

Tony L. White Keynote Address at "Personalized Medicine: A World of Opportunities" Conference
Tuesday, November 28, 2006 | Boston, MA
Click here to view webcast

Annual Report

View the Applera Corporation 2007 Annual Report [.pdf file]		 View the Applera Corporation 2007 Annual Report

Recent News

May 14, 2008
Celera to Webcast Presentation at Seventh Annual JMP Securities Research Conference

May 9, 2008
Applera Corporation's Board of Directors Formally Approves Proposed Separation of Its Celera Business

April 24, 2008
Celera Reports Third Quarter Fiscal 2008 Results

Additional
Applera Corporation Teleconference April 24, 2008 Management Remarks for Third Quarter Fiscal 2008 Earnings Call


Disease Association Studies Results
March 2008 - Celera Publishes Gene Variants Associated With Deep Vein Thrombosis

January 2008 - Celera publishes Association of the Trp719Arg Polymorphism in Kinesin-Like Protein 6 With Myocardial Infarction and Coronary Heart Disease in 2 Prospective Trials: The CARE and WOSCOPS Trials

January 2008 - Celera publishes A Kinesin Family Member 6 Variant Is Associated With Coronary Heart Disease in the Women’s Health Study.

CONTACT SITE MAP SEARCH Submit  
© 2008 Celera. All Rights Reserved.   | Privacy Statement | Terms of Use | Investor Advisories | Prescription Drug Marketing Policy
built@zoomedia